The cytotoxic effect of gefitinib with or without IL-22 was further examined by Ki67 (a biomarker of tumor proliferation) and TUNEL staining analysis (evaluation of tumor apoptosis; Figure 6). The gene discussed is IL22; the disease is neoplasm.